[Tyr0]-Neurokinin B is a modified tachykinin analog incorporating an N-terminal tyrosine for enhanced detection or labeling strategies. Its structure supports receptor-binding assessments and motif mapping. Researchers examine its conformational shifts to evaluate ligand-receptor compatibility. The peptide contributes to targeted neuroendocrine signaling studies.
CAT No: N1809
1. Emu oil in combination with other active ingredients for treating skin imperfections
2. The spatiotemporal control of signalling and trafficking of the GLP-1R
3. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More